Julia Senkiv is a highly skilled researcher with extensive experience in biochemistry and cancer research. Currently serving as a Postdoctoral Researcher at the St. Anna Children's Cancer Research Institute, Julia is focused on mutation-associated resistance mechanisms in Ph+ leukemias. Previous roles include Research Technician at the Institute of Science and Technology Austria, where Julia enhanced laboratory efficiency and coordinated staff training programs. A strong academic background includes multiple PhD fellowships and training in neuroscience, complemented by positions at prestigious institutions such as Medical University of Vienna and Danylo Halytskyi Lviv National Medical University. Julia holds a PhD in Biochemistry from both the Palladin Institute of Biochemistry and Ivan Franko National University of Lviv.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).